MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 41 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.18 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $6,882,000 | +88.1% | 1,156,626 | +100.0% | 0.39% | +28.3% |
Q1 2022 | $3,658,000 | +74.0% | 578,313 | +7.6% | 0.31% | +120.9% |
Q4 2021 | $2,102,000 | -20.7% | 537,584 | -2.1% | 0.14% | -28.4% |
Q3 2021 | $2,651,000 | -24.4% | 548,836 | 0.0% | 0.19% | -22.4% |
Q2 2021 | $3,507,000 | +1.4% | 548,836 | -0.3% | 0.25% | -36.2% |
Q1 2021 | $3,458,000 | -5.6% | 550,679 | +3.6% | 0.39% | -32.3% |
Q4 2020 | $3,662,000 | +78.5% | 531,510 | 0.0% | 0.58% | +60.4% |
Q3 2020 | $2,052,000 | – | 531,510 | – | 0.36% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Western Standard LLC | 1,894,013 | $23,353,180 | 21.09% |
Newtyn Management, LLC | 1,873,694 | $23,102,647 | 5.70% |
Sio Capital Management, LLC | 288,466 | $3,556,786 | 1.10% |
Madison Avenue Partners, LP | 553,085 | $6,819,538 | 0.97% |
WITTENBERG INVESTMENT MANAGEMENT, INC. | 209,739 | $2,586 | 0.95% |
Indaba Capital Management, L.P. | 136,802 | $1,686,769 | 0.50% |
Sepio Capital, LP | 306,680 | $3,781,364 | 0.33% |
Yakira Capital Management, Inc. | 54,118 | $667,275 | 0.18% |
Centiva Capital, LP | 187,803 | $2,315,611 | 0.05% |
FIFTH LANE CAPITAL, LP | 10,929 | $134,427 | 0.05% |